Louvain Drug Research Institute, Advanced Drug Delivery and Biomaterials, Université catholique de Louvain, Avenue Mounier, 73, B1 73.12, 1200, Brussels, Belgium.
Integrated Center for Cell Therapy and Regenerative Medicine, International Clinical Research Center (FNUSA-ICRC), St. Anne's University Hospital Brno, Pekařská 53, 656 91, Brno, Czech Republic.
Stem Cell Rev Rep. 2017 Aug;13(4):499-512. doi: 10.1007/s12015-017-9742-4.
Oligodendrocyte progenitor cells (OPCs) play a pivotal role in both health and disease within the central nervous system, with oligodendrocytes, arising from resident OPCs, being the main myelinating cell type. Disruption in OPC numbers can lead to various deleterious health defects. Numerous studies have described techniques for isolating OPCs to obtain a better understanding of this cell type and to open doors for potential treatments of injury and disease. However, the techniques used in the majority of these studies involve several steps and are time consuming, with current culture protocols using serum and embryonic or postnatal cortical tissue as a source of isolation. We present a primary culture method for the direct isolation of functional adult rat OPCs, identified by neuron-glial antigen 2 (NG2) and platelet derived growth factor receptor alpha (PDGFrα) expression, which can be obtained from the adult spinal cord. Our method uses a simple serum-free cocktail of 3 growth factors - FGF, PDGF, and IGF-I, to expand adult rat OPCs in vitro to 96% purity. Cultured cells can be expanded for at least 10 passages with very little manipulation and without losing their phenotypic progenitor cell properties, as shown by immunocytochemistry and RT-PCR. Cultured adult rat OPCs also maintain their ability to differentiate into GalC positive cells when incubated with factors known to stimulate their differentiation. This new isolation method provides a new source of easily accessible adult stem cells and a powerful tool for their expansion in vitro for studies aimed at central nervous system repair.
少突胶质前体细胞(OPCs)在中枢神经系统的健康和疾病中发挥着关键作用,由驻留的 OPC 产生的少突胶质细胞是主要的髓鞘形成细胞类型。OPC 数量的减少会导致各种有害的健康缺陷。许多研究都描述了分离 OPC 的技术,以更好地了解这种细胞类型,并为损伤和疾病的潜在治疗方法开辟道路。然而,大多数这些研究中使用的技术涉及多个步骤,并且很耗时,目前的培养方案使用血清和胚胎或出生后皮质组织作为分离的来源。我们提出了一种直接分离功能成熟大鼠 OPC 的原代培养方法,该方法通过神经元-胶质抗原 2 (NG2) 和血小板衍生生长因子受体 α (PDGFrα) 的表达来鉴定,这些 OPC 可以从成年脊髓中获得。我们的方法使用了一种简单的无血清鸡尾酒 3 种生长因子 - FGF、PDGF 和 IGF-I,以将成年大鼠 OPC 体外扩增到 96%的纯度。培养的细胞可以至少扩增 10 代,只需很少的操作,并且不会失去其表型祖细胞特性,如免疫细胞化学和 RT-PCR 所示。培养的成年大鼠 OPC 在与已知能刺激其分化的因子孵育时,仍能保持分化为 GalC 阳性细胞的能力。这种新的分离方法为容易获得的成年干细胞提供了新的来源,并为其在体外扩增提供了有力的工具,用于旨在修复中枢神经系统的研究。